BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 17075565)

  • 1. Lymphangioleiomyomatosis.
    Taveira-DaSilva AM; Steagall WK; Moss J
    Cancer Control; 2006 Oct; 13(4):276-85. PubMed ID: 17075565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphangioleiomyomatosis: A review.
    Hohman DW; Noghrehkar D; Ratnayake S
    Eur J Intern Med; 2008 Jul; 19(5):319-24. PubMed ID: 18549932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.
    Taveira-DaSilva AM; Pacheco-Rodriguez G; Moss J
    Lymphat Res Biol; 2010 Mar; 8(1):9-19. PubMed ID: 20235883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular insights into lymphangioleiomyomatosis.
    Steagall WK; Taveira-DaSilva AM; Moss J
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S49-66. PubMed ID: 16457017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).
    Urban T; Lazor R; Lacronique J; Murris M; Labrune S; Valeyre D; Cordier JF
    Medicine (Baltimore); 1999 Sep; 78(5):321-37. PubMed ID: 10499073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphangioleiomyomatosis.
    Kelly J; Moss J
    Am J Med Sci; 2001 Jan; 321(1):17-25. PubMed ID: 11202475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary lymphangioleiomyomatosis: report of one case].
    Silva O R; Puelma C F; Retamal P V; Rojas Sm P; Cruzat C C; Reyes G C
    Rev Med Chil; 2009 Nov; 137(11):1474-7. PubMed ID: 20098807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-Small Lung Cysts Impair Diffusion Without Obstructing Air Flow in Lymphangioleiomyomatosis.
    Matthew BP; Hasani AM; Chen YC; Pirooznia M; Stylianou M; Rollison SF; Machado TR; Quade NM; Jones AM; Julien-Williams P; Taveira-DaSilva A; Chen MY; Moss J; Wen H
    Chest; 2021 Jul; 160(1):199-208. PubMed ID: 33549601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis.
    Taveira-DaSilva AM; Moss J
    Clin Epidemiol; 2015; 7():249-57. PubMed ID: 25897262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features.
    Ferrans VJ; Yu ZX; Nelson WK; Valencia JC; Tatsuguchi A; Avila NA; Riemenschn W; Matsui K; Travis WD; Moss J
    J Nippon Med Sch; 2000 Oct; 67(5):311-29. PubMed ID: 11031360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.
    Taveira-DaSilva AM; Hathaway O; Stylianou M; Moss J
    Ann Intern Med; 2011 Jun; 154(12):797-805, W-292-3. PubMed ID: 21690594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in Japanese patients with tuberous sclerosis complex.
    Tanaka M; Hirata H; Wataya-Kaneda M; Yoshida M; Katayama I
    Respir Investig; 2016 Jan; 54(1):8-13. PubMed ID: 26718139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary lymphangioleiomyomatosis: From pathogenesis to management].
    Chebib N; Khouatra C; Lazor R; Archer F; Leroux C; Gamondes D; Thivolet-Bejui F; Cordier JF; Cottin V
    Rev Mal Respir; 2016 Oct; 33(8):718-734. PubMed ID: 26604019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphangioleiomyomatosis: pulmonary and abdominal findings with pathologic correlation.
    Pallisa E; Sanz P; Roman A; Majó J; Andreu J; Cáceres J
    Radiographics; 2002 Oct; 22 Spec No():S185-98. PubMed ID: 12376610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When to suspect and how to diagnose pulmonary lymphangioleiomyomatosis.
    Naalsund A; Johansen B; Foerster A; Kolbenstvedt A
    Respirology; 1996 Sep; 1(3):207-12. PubMed ID: 9424398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphangioleiomyomatosis.
    Doubková M; Štefániková M; Čan V; Merta Z; Svoboda M
    Klin Onkol; 2019; 32(5):367-374. PubMed ID: 31610670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex.
    Moss J; Avila NA; Barnes PM; Litzenberger RA; Bechtle J; Brooks PG; Hedin CJ; Hunsberger S; Kristof AS
    Am J Respir Crit Care Med; 2001 Aug; 164(4):669-71. PubMed ID: 11520735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary lymphangioleiomyomatosis: literature update.
    Valentín-Mendoza S; Nieves-Nieves J; Fernández-Medero R; Fernández-Gonzales R; Adorno-Fontánez J; Adorno-Fontánez E
    Bol Asoc Med P R; 2013; 105(3):64-9. PubMed ID: 24282925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of pulmonary lymphangioleiomyomatosis and pulmonary angiomyolipoma.
    Sun X; Feng R; Zhang Y; Shi J; Xu KF
    BMC Pulm Med; 2016 Aug; 16(1):120. PubMed ID: 27527652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphangioleiomyomatosis.
    Johnson SR
    Eur Respir J; 2006 May; 27(5):1056-65. PubMed ID: 16707400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.